期刊
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
卷 223, 期 -, 页码 -出版社
ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2021.113607
关键词
Adenosine; Boron cluster; Agonists; Antagonists; Selectivity; Nucleosides; Purinergic receptors
资金
- National Science Center, Poland [2014/13/B/NZ1/03989]
- NIDDK Intramural Program grant [ZIA DK031117]
- IMB PAS
- Center for Preclinical Research and Technology (CePT)
- European Regional Development Fund
- Innovative Economy, The National Cohesion Strategy of Poland
A series of adenosine and 2'-deoxyadenosine pairs modified with a boron cluster or phenyl group showed a general tendency to preferentially bind to the A(3) adenosine receptor. Boron cluster-modified ligands exhibited higher A(3) receptor selectivity compared to phenyl analogs.
A series of adenosine and 2 '-deoxyadenosine pairs modified with a 1,12-dicarba-closo-dodecaborane cluster or alternatively with a phenyl group at the same position was synthesized, and their affinity was determined at A(1), A(2A), A(2B) and A(3) adenosine receptors (ARs). While AR affinity differences were noted, a general tendency to preferentially bind A(3) AR over other ARs was observed for most tested ligands. In particular, 5 '-ethylcarbamoyl-N-6-(3-phenylpropyl)adenosine (18), N-6-(3-phenylpropyl)-2-chloroadenosine (24) and N-6-(3-phenylpropyl)adenosine (40) showed nanomolar A(3) affinity (K-i 4.5, 6.4 and 7.5 nM, respectively). Among the boron cluster-containing compounds, the highest A(3) affinity (K-i 206 nM) was for adenosine derivative 41 modified at C2. In the matched molecular pairs, analogs bearing boron clusters were found to show lower binding affinity for adenosine receptors than the corresponding phenyl analogs. Nevertheless, interestingly, several boron cluster modified adenosine ligands showed significantly higher A(3) receptor selectivity than the corresponding phenyl analogs: 7 vs. 8, 15 vs. 16, 17 vs. 18. (C) 2021 Elsevier Masson SAS. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据